Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Visa Class B stockholder liquidity program and $100 billion exchange offer
We advised Visa on the design and implementation of its Class B stockholder liquidity program and inaugural exchange offer
ADC Therapeutics $105 million follow-on offering
We advised ADC Therapeutics on its offering of shares and pre-funded warrants
GXO Logistics $1.1 billion notes offering
The investment-grade notes are due 2029 and 2034
Bombardier cash tender offer
The company purchased certain debt securities
Uniti Group merger with Windstream
We are advising Uniti Group on the transaction
AZZ $322 million follow-on offering
The shares are listed on the NYSE
Canada $3 billion global bond offering
The investment-grade bonds are due 2029
Puig €2.6 billion IPO
Puig’s Class B shares are listed on the Spanish Stock Exchanges
UMB Financial $2 billion acquisition of Heartland Financial
We are advising UMB on the acquisition and a $201.6 million stock offering
Aon $3.4 billion cash tender offers and consent solicitations
The company purchased certain debt securities of NFP